Area of expertise
Consultant, epidemiology and vaccine-preventable diseases (yellow fever)
Purpose of consultancy
To build outbreak preparedness, detection and response capacity in Cameroon, the Central African Republic and Guinea.
Background
Yellow fever (YF) is a serious viral haemorrhagic disease that poses a challenge for surveillance systems, with high-impact and high-threat. Due to its risk of international spread, it represents a potential threat to global health security. YF epidemics are complex, with multi-factorial and evolving nature of risk and its inherent unknowns. The threat of YF outbreaks continues to affect countries in Africa and the Americas. The unprecedented urban outbreaks in 2016 demonstrated that despite the advances in immunization activities, challenges remain in ending YF epidemics.
Countries at risk of Yellow Fever (YF) are prioritizing efforts to enhance population immunity, focusing particularly on high-risk communities. Key strategies include: 1) strengthening surveillance to better identify and protect susceptible populations, 2) projecting the number of individuals who could benefit from YF vaccination and ensuring these populations, including migrants, are vaccinated, 3) improving surveillance systems to differentiate YF from other arboviral diseases and 4) enhancing data collection to better understand sub-national risks, such as the distribution of non-human primates (NHPs) and mosquito vectors.
The International Coordination Group (ICG) on Vaccine Provision was established in 1997 following major outbreaks of meningitis in Africa as a mechanism to manage and coordinate the provision of emergency vaccine, supplies and antibiotics to countries during major outbreaks. Currently the ICG monitors global licensed vaccine stock levels for cholera, meningococcal meningitis, yellow fever, and Ebola virus disease to ensure availability of sufficient supplies to respond to disease outbreaks. The ICG brings together partners to improve coordination of epidemic preparedness and response, including UNICEF, Médecins sans Frontières and the International Federation of the Red Crescent. The ICG works on forecasting licensed vaccine stocks, negotiating prices through its networks and partners.
Between 2022 and 2024, Cameroon, the Central African Republic, and Guinea reported yellow fever cases in regions that had previously undergone vaccination campaigns, whether reactive or preventive. A root cause analysis in these countries revealed gaps in routine immunization and yellow fever surveillance that need strengthening. Corrective actions were identified and are now ready to be integrated into national recovery plans. Additionally, an evaluation of delays in implementing reactive vaccination campaigns in Guinea and Cameroon was conducted. A list of corrective actions was developed, and its implementation is now set to effectively reduce delays in outbreak response.
The global strategy to Eliminate Yellow Fever Epidemics (EYE) is a comprehensive and long-term strategy built on lessons learned that aims at ending YF epidemics by 2026. It was developed by a coalition of partners (Gavi, UNICEF and WHO) to face yellow fever’s changing epidemiology, resurgence of mosquitoes, and the increased risk of urban outbreaks and international spread. The strategy consists of three strategic objectives: 1) protect at-risk populations, 2) prevent international spread; and 3) contain outbreaks rapidly. Activities supported through the EYE Strategy contribute to the triple billion goal of the Thirteenth General Programme of Work of WHO (GPW13) by implementing large-scale interventions to prevent epidemics.
Deliverables
- Output 1: Coordinate countries’ responses for early detection and timely response to yellow fever cases.
- Output 1.1: Act as the yellow fever focal point at the World Health Organization Country Office and liaise with both the Expanded Programme on Immunization and Emergency departments for optimal coordination.
- Output 1.2: Conduct investigations of suspected yellow fever cases, final classification of yellow fever cases, clinical description of cases, and triangulation of different sources of information with national health authorities.
- Output 1.3: Update yellow fever detection and control plans of the national health authorities, including the urban preparedness component, and integrate them into the national EYE strategy plans as relevant.
- Output 1.4: Provide surge support to countries affected by yellow fever outbreaks.
- Output 2: Facilitate timely vaccination response to yellow fever vaccines under the International Coordination Group mechanism.
- Output 2.1: Implement mitigation measures identified during the evaluation of outbreak response delays in conjunction with the national health authorities to ensure timely reactive vaccination campaigns.
- Output 2.2: Review ICG requests, including the budget, with national health authorities for preparation and submission.
- Output 2.3: Develop reactive vaccination response plans with national health authorities.
- Output 2.4: Review ICG request comments upon their deliberation with the national health authorities.
- Output 2.5: Draft microplanning activities related to reactive vaccination campaigns with the national health authorities.
- Output 2.6: Develop post-campaign coverage survey protocols in line with 2018 World Health Organization Immunization, Vaccines, and Biologicals Department guidance with the national health authorities.
- Output 3: Facilitate countries in developing routine immunization and catch-up vaccination planning to roll out reactive vaccination campaigns for yellow fever.
- Output 3.1: Coordinate the implementation of measures identified during root cause analysis to strengthen routine immunization for yellow fever with national health authorities.
- Output 3.2: Develop a national catch-up/targeted mass vaccination campaign plan based on immunity gap analysis.
- Output 3.3: Conduct training of national health authorities on the above-mentioned topics.
Qualifications, experience, skills and languages
Educational Qualifications
Essential
An advanced level university degree in epidemiology, medicine, public health or related field. Formal training in epidemiology.
Desirable
Training in applied epidemiology would be an asset.
Experience
Essential
- At least seven years of relevant experience working at national/international level in epidemiology conducting monitoring and evaluation of diseases and public health issues related to epidemic-prone diseases.
- Field experience in the African region.
Desirable
Experience with the United Nations agencies, such as the World Health Organization (WHO), United Nations Children’s Fund (UNICEF), the Centers for Disease Control and Prevention (US CDC), Médecins sans Frontières (MSF), or a health cluster member organization.
Skills/Knowledge
Essential
- Demonstrated knowledge, competency and professional skills on the public health aspects of infectious disease epidemiology, prevention and control.
- Strong knowledge of disease surveillance systems, understanding of field outbreak response operations.
- Proven ability in managing and analysing public health data sets, including large databank sets.
- Ability to work with governments to implement immunization initiatives.
- Excellent communication and presentation skills.
- Ability to work as a team with a variety of stakeholders and meet deadlines.
- Proficiency in the Microsoft office suite of applications (Word, Excel, PowerPoint, Teams, SharePoint) and remote working technologies.
Desirable
- Background/familiarity with emergency settings.
- Expertise in vaccination coverage surveys.
- Sound knowledge of vaccine preventable diseases.
- Sound knowledge of yellow fever surveillance.
Languages and level required (Basic/Intermediate/Expert)
Essential
- Expert knowledge of written and spoken English and French
- Working knowledge of other UN language is an advantage
Desirable
Intermediate knowledge of Spanish or any other UN official language
Location
Onsite – consultant to be based in one of the following countries: Cameroon, Central African Republic, Guinea
Travel
The consultant is expected to travel.
Remuneration and budget (travel)
Remuneration
Band level B – USD 7,000 – 9,980 per month.
Living expenses
Living allowance is payable to onsite consultant
Expected duration of contract
A contract up to 11 months might be offered. Additional contracts may be offered based on programme needs and availability of funds.
Additional Information
- This vacancy notice may be used to identify candidates for other similar consultancies at the same level.
- Only candidates under serious consideration will be contacted.
- A written test may be used as a form of screening.
- If your candidature is retained for interview, you will be required to provide, in advance, a scanned copy of the degree(s)/diploma(s)/certificate(s) required for this position. WHO only considers higher educational qualifications obtained from an institution accredited/recognized in the World Higher Education Database (WHED), a list updated by the International Association of Universities (IAU)/United Nations Educational, Scientific and Cultural Organization (UNESCO). The list can be accessed through the link: http://www.whed.net/. Some professional certificates may not appear in the WHED and will require individual review.
- For information on WHO’s operations please visit: http://www.who.int.
- The WHO is committed to creating a diverse and inclusive environment of mutual respect. The WHO recruits workforce regardless of disability status, sex, gender identity, sexual orientation, language, race, marital status, religious, cultural, ethnic and socio-economic backgrounds, or any other personal characteristics.
The WHO is committed to achieving gender parity and geographical diversity in its workforce. Women, persons with disabilities, and nationals of unrepresented and underrepresented Member States (https://www.who.int/careers/diversity-equity-and-inclusion) are strongly encouraged to apply for WHO jobs.
Persons with disabilities can request reasonable accommodations to enable participation in the recruitment process. Requests for reasonable accommodation should be sent through an email to reasonableaccommodation@who.int - An impeccable record for integrity and professional ethical standards is essential. WHO prides itself on a workforce that adheres to the highest ethical and professional standards and that is committed to put the WHO Values Charter (https://www.who.int/about/who-we-are/our-values) into practice.
- WHO has zero tolerance towards sexual exploitation and abuse (SEA), sexual harassment and other types of abusive conduct (i.e., discrimination, abuse of authority and harassment). All members of the WHO workforce have a role to play in promoting a safe and respectful workplace and should report to WHO any actual or suspected cases of SEA, sexual harassment and other types of abusive conduct. To ensure that individuals with a substantiated history of SEA, sexual harassment or other types of abusive conduct are not hired by the Organization, WHO will conduct a background verification of short-listed candidates.
- WHO has a smoke-free environment and does not recruit smokers or users of any form of tobacco.
- Consultants shall perform the work as independent contractors in a personal capacity, and not as a representative of any entity or authority.
- WHO shall have no responsibility for any taxes, duties, social security contributions or other contributions payable by the Consultant. The Consultant shall be solely responsible for withholding and paying any taxes, duties, social security contributions and any other contributions which are applicable to the Consultant in each location/jurisdiction in which the work hereunder is performed, and the Consultant shall not be entitled to any reimbursement thereof by WHO.
- Please note that WHO’s contracts are conditional on members of the workforce confirming that they are vaccinated as required by WHO before undertaking a WHO assignment, except where a medical condition does not allow such vaccination, as certified by the WHO Staff Health and Wellbeing Services (SHW). The successful candidate will be asked to provide relevant evidence related to this condition. A copy of the updated vaccination card must be shared with WHO medical service in the medical clearance process. Please note that certain countries require proof of specific vaccinations for entry or exit. For example, official proof /certification of yellow fever vaccination is required to enter many countries. Country-specific vaccine recommendations can be found on the WHO international travel and Staff Health and Wellbeing website. For vaccination-related queries please directly contact SHW directly at shws@who.int.
- In case the recruitment website does not display properly, please retry by: (i) checking that you have the latest version of the browser installed (Chrome, Edge or Firefox); (ii) clearing your browser history and opening the site in a new browser (not a new tab within the same browser); or (iii) retry accessing the website using Mozilla Firefox browser or using another device. Click the link for detailed guidance on completing job applications: Instructions for candidates .
..